Mayo has teamed up with Enterprise Ireland, a company that helps promote Irish manufacturing. Enterprise will take more than 20 of Mayo’s early stage medical devices and treatments — researched and developed in Rochester — and work with Irish universities to turn the developments into “market-ready” products, according to an Irish Independent report. The Irish government will commit about $16.6 million in funding to help the program.
Mayo has said preparing research products for market in the U.S. has become more expensive, according to the Minneapolis/St. Paul Business Journal report. The first project under the partnership — a device for treating acute pancreatitis —is being developed at the National University of Ireland in Galway.
More Articles on Mayo Clinic:
12 Things to Know About Mayo Clinic
Mayo Clinic to Add Up to 1,000 Physicians With Destination Medical Center
Mayo Clinic’s Operating Profit Soars to $612M in 2013
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
